| 应用 |
A potent, selective and reversible inhibitor of JNK1, JNK-2, and JNK-3 |
| 产品介绍 |
SP600125是泛JNK抑制剂，对JNK1，JNK2和JNK3的IC50分别为40 nM，40 nM和90 nM，比对MKK4和MKK3，MKK6，PKB，PKCα的抑制性高10倍和超过25倍。 |
| 备注 |
SP600125 is a broad-spectrum JNK inhibitor for JNK1, JNK2 and JNK3 with IC50 of 40 nM, 40 nM and 90 nM, respectively; 10-fold greater selectivity against MKK4, 25-fold greater selectivity against MKK3, MKK6, PKB, and PKCα, and 100-fold selec |
| 生化机理 |
SP600125 is selective inhibitor of c-Jun N-terminal kinase (JNK). SP600125 competitively and reversibly inhibits JNK1, 2 and 3 (IC50 = 40 - 90 nM) with negligible activity at ERK2, p38β and a range of enzymes (IC50 > 10 μM). Active in vivo. Shown to have reduced selectivity over other protein kinases under certain conditions. Protects renal tubular epithelial cells against ischemia/reperfusion-induced apoptosis. |
| 别名 |
吡唑蒽酮; 蒽并[1,9-cd]吡唑-6(2H)-酮;SP 600125;SP-600125;1,9-Pyrazoloanthrone;Anthra[1,9-cd]pyrazol-6(2H)-one;JNK Inhibitor II |
